Everything You Need to Know About the O-Shot and M-Shot
By: The Hidden Epidemic of Sexual Health and What We Can Do
Tempe 480.968.5673
Glendale 602.374.3374
Phoenix 602.441.3305
Chandler480.447.1165
Tempe 480.968.5673
Glendale 602.374.3374
Phoenix 602.441.3305
Chandler480.447.1165
SIBO Testing Available In-home breath testing$225Call our office (602) 441-3305 Understanding the Role of Gut Motility and SIBO GLP-1 medications have helped many people take control of their weight in a way that finally feels sustainable. By supporting appetite regulation, improving insulin sensitivity, and slowing digestion, these medications help reduce
In-home breath testing
$225
Call our office (602) 441-3305
GLP-1 medications have helped many people take control of their weight in a way that finally feels sustainable. By supporting appetite regulation, improving insulin sensitivity, and slowing digestion, these medications help reduce overeating and promote steady progress.
But for some patients, that progress eventually slows. Weight loss plateaus. Bloating becomes more noticeable. Constipation lingers. Meals feel heavier than they used to. When this happens, it is easy to assume the medication is no longer effective.
In reality, weight loss plateaus are often driven by physiology rather than effort. One factor that is increasingly recognized in clinical research is digestive health, particularly gut motility and a condition known as Small Intestinal Bacterial Overgrowth, or SIBO.
Clinical guidance from the American Gastroenterological Association identifies SIBO as a condition commonly associated with bloating, abdominal discomfort, and altered bowel habits, all of which can complicate metabolic progress when left unaddressed.
Subscribe for expert insights on building confidence, overcoming mental barriers, and achieving lasting weight loss success. Join patients who are transforming both body and mind.Join our newsletter for expert insights on treating melasma, hyperpigmentation, and other skin concerns. Our medical aesthetic team shares practical advice to help you achieve clear, radiant skin.
SIBO occurs when bacteria that normally reside in the large intestine begin to overgrow in the small intestine. The small intestine plays a primary role in nutrient digestion and absorption and is not designed to host large bacterial populations.
When excess bacteria are present in this area, food can ferment prematurely. This fermentation produces gas and byproducts that interfere with digestion and nutrient absorption.
According to clinical guidance published by the American College of Gastroenterology, common symptoms associated with SIBO include bloating, abdominal discomfort, gas, diarrhea, and constipation. Nutrient deficiencies may also occur in some patients, particularly with prolonged overgrowth.
Common symptoms that may suggest SIBO
Because several of these symptoms overlap with known digestive side effects of GLP-1 medications, SIBO can be difficult to recognize without further evaluation.
Gut motility refers to how efficiently food and waste move through the digestive tract. When motility slows, bacteria have more time to remain in the small intestine, increasing the risk of bacterial overgrowth.
GLP-1 receptor agonists are known to slow gastric emptying and intestinal transit. This mechanism supports appetite control and blood sugar stability, and it is one of the reasons these medications are effective. Research published in the Journal of Clinical Endocrinology & Metabolism explains that delayed gastric emptying is a central part of GLP-1’s therapeutic effect.
For some individuals, however, this slowing of digestion may contribute to constipation, bloating, and prolonged fullness. Over time, reduced motility can create conditions that allow bacterial populations to expand in areas where they do not belong.
The Relationship Between Obesity, SIBO, and Metabolism
Research has shown that individuals with obesity are more likely to experience changes in gut microbiota composition. These changes can affect how calories are absorbed, how inflammation is regulated, and how metabolic hormones function.
A study published in Digestive Diseases and Sciences found that SIBO was significantly more prevalent in individuals with obesity compared to non-obese individuals. Other research has linked gut dysbiosis with insulin resistance and altered energy extraction from food.
This is important because many patients begin GLP-1 therapy with pre-existing digestive and metabolic challenges that may not be obvious at first.
Increased energy extraction from food
Certain gut bacteria are more efficient at extracting calories from food. Methane-producing organisms, in particular, have been associated with slower intestinal transit and increased energy absorption. Research published in the American Journal of Gastroenterology has shown a relationship between methane on breath testing and constipation, which can further slow digestion.
Even with reduced food intake, increased calorie extraction can make weight loss more difficult.
Disruption of appetite and metabolic hormones
The gut plays a critical role in hormone regulation, including GLP-1, insulin, ghrelin, and peptide YY. Bacterial overgrowth can disrupt these signaling pathways, making the body less responsive to appetite cues and metabolic regulation.
Chronic low-grade inflammation
SIBO can contribute to inflammation within the intestinal lining. Chronic inflammation has been linked to insulin resistance and impaired fat metabolism, both of which can interfere with weight loss progress.
Nutrient malabsorption
Clinical guidance from gastroenterology organizations notes that SIBO may be associated with nutrient deficiencies, including vitamin B12 and iron. When nutrient absorption is impaired, energy levels, thyroid function, and metabolic efficiency may suffer.
Many GLP-1 patients experience temporary digestive symptoms when starting treatment or adjusting doses. Because bloating and constipation are expected side effects for some individuals, persistent symptoms may be dismissed or normalized.
However, when digestive discomfort continues for weeks or months, or when it coincides with a prolonged weight loss plateau, further evaluation may be appropriate. Gastroenterology guidelines emphasize that persistent symptoms warrant investigation rather than assumption.
Breath testing is a widely used, noninvasive method for evaluating bacterial fermentation patterns in the gut. The American College of Gastroenterology recognizes hydrogen and methane breath testing as a diagnostic tool when SIBO is suspected.
The test measures gas production after ingestion of a specific substrate. Elevated hydrogen or methane levels can help identify bacterial overgrowth and provide insight into gut motility patterns.
Interested in testing for SIBO?
Our office offers convenient at-home SIBO breath testing. We can ship the test directly to you for use in the comfort of your home.
In-home testing is available for $225.
Call (602) 441-3305 to learn more and see if testing is right for you.
Treatment for SIBO is individualized and should be guided by a healthcare provider. Clinical guidelines describe antibiotics as a primary treatment option in many cases, often combined with dietary strategies and motility support.
Management may include:
Many patients can continue GLP-1 therapy while addressing gut health, depending on symptom severity and clinical findings.
You may benefit from speaking with a healthcare provider if you experience:
Addressing gut health does not mean GLP-1 therapy has failed. It often means additional support is needed.
Weight loss is influenced by more than appetite alone. Digestion, hormone signaling, inflammation, and nutrient absorption all play a role in how the body responds to treatment.
By evaluating gut health alongside metabolic care, patients may uncover treatable barriers that allow weight loss strategies to work more effectively and comfortably.
Can SIBO cause weight loss plateaus while on GLP-1 medications?
Yes. SIBO can interfere with digestion, nutrient absorption, and hormone signaling. These factors can contribute to bloating, constipation, and metabolic inefficiency, which may make weight loss slower or stall despite consistent GLP-1 use.
Is bloating normal on GLP-1 medications?
Some bloating can occur, especially during the early stages of treatment or when doses are increased. However, persistent or worsening bloating that does not improve over time may indicate an underlying digestive issue such as slowed gut motility or bacterial overgrowth.
Do GLP-1 medications slow digestion?
Yes. GLP-1 medications are designed to slow gastric emptying and digestion. This helps increase feelings of fullness and regulate blood sugar. In some individuals, slower digestion may also contribute to constipation or digestive discomfort.
What is the connection between gut motility and SIBO?
Healthy gut motility helps move bacteria through the digestive tract. When motility slows, bacteria can remain in the small intestine longer than intended, increasing the risk of bacterial overgrowth. Slower motility is a known factor in SIBO development.
How is SIBO diagnosed?
SIBO is commonly evaluated using a breath test that measures hydrogen and methane gases after consuming a test solution. This noninvasive test helps identify bacterial fermentation patterns that may indicate overgrowth.
Can SIBO be treated while continuing GLP-1 therapy?
In many cases, yes. Treatment plans are individualized, but addressing gut health does not always require stopping GLP-1 medication. A healthcare provider can determine the safest and most effective approach based on symptoms and test results.
Does constipation affect weight loss results?
Constipation can increase bloating, discomfort, and day-to-day scale fluctuations. It can also slow digestive transit further, which may affect how the body processes nutrients and responds to weight loss efforts.
When should I talk to a provider about digestive symptoms?
You should consider speaking with a healthcare provider if you experience ongoing bloating, constipation, abdominal discomfort, fatigue, or a prolonged weight loss plateau that does not improve with time or standard adjustments.
Can gut health affect metabolism?
Yes. Gut health plays an important role in hormone regulation, inflammation, nutrient absorption, and energy balance. Digestive imbalances can influence how the body responds to weight loss treatments.
Are digestive symptoms a sign that GLP-1 medications are not working?
Not necessarily. Digestive symptoms often reflect how the body is adapting. Persistent symptoms may signal that additional evaluation or support is needed rather than a failure of the medication itself.
If you are experiencing persistent bloating, constipation, or stalled weight loss while on GLP-1 therapy, testing for SIBO may provide helpful insight.
Our team offers in-home SIBO breath testing for $225, with tests shipped directly to you.
This content is for educational purposes only and is not intended to diagnose or treat any condition. Individual results may vary. Always consult with a qualified healthcare provider regarding symptoms, medications, or treatment options.
By Dr. Samuel Zuniga, ND
Valley Medical Weight Loss | Chandler, Arizona
In-home breath testing
$225
Call our office (602) 441-3305
GLP-1 medications have helped many people take control of their weight in a way that finally feels sustainable. By supporting appetite regulation, improving insulin sensitivity, and slowing digestion, these medications help reduce overeating and promote steady progress.
But for some patients, that progress eventually slows. Weight loss plateaus. Bloating becomes more noticeable. Constipation lingers. Meals feel heavier than they used to. When this happens, it is easy to assume the medication is no longer effective.
In reality, weight loss plateaus are often driven by physiology rather than effort. One factor that is increasingly recognized in clinical research is digestive health, particularly gut motility and a condition known as Small Intestinal Bacterial Overgrowth, or SIBO.
Clinical guidance from the American Gastroenterological Association identifies SIBO as a condition commonly associated with bloating, abdominal discomfort, and altered bowel habits, all of which can complicate metabolic progress when left unaddressed.
Subscribe for expert insights on building confidence, overcoming mental barriers, and achieving lasting weight loss success. Join patients who are transforming both body and mind.Join our newsletter for expert insights on treating melasma, hyperpigmentation, and other skin concerns. Our medical aesthetic team shares practical advice to help you achieve clear, radiant skin.
SIBO occurs when bacteria that normally reside in the large intestine begin to overgrow in the small intestine. The small intestine plays a primary role in nutrient digestion and absorption and is not designed to host large bacterial populations.
When excess bacteria are present in this area, food can ferment prematurely. This fermentation produces gas and byproducts that interfere with digestion and nutrient absorption.
According to clinical guidance published by the American College of Gastroenterology, common symptoms associated with SIBO include bloating, abdominal discomfort, gas, diarrhea, and constipation. Nutrient deficiencies may also occur in some patients, particularly with prolonged overgrowth.
Common symptoms that may suggest SIBO
Because several of these symptoms overlap with known digestive side effects of GLP-1 medications, SIBO can be difficult to recognize without further evaluation.
Gut motility refers to how efficiently food and waste move through the digestive tract. When motility slows, bacteria have more time to remain in the small intestine, increasing the risk of bacterial overgrowth.
GLP-1 receptor agonists are known to slow gastric emptying and intestinal transit. This mechanism supports appetite control and blood sugar stability, and it is one of the reasons these medications are effective. Research published in the Journal of Clinical Endocrinology & Metabolism explains that delayed gastric emptying is a central part of GLP-1’s therapeutic effect.
For some individuals, however, this slowing of digestion may contribute to constipation, bloating, and prolonged fullness. Over time, reduced motility can create conditions that allow bacterial populations to expand in areas where they do not belong.
The Relationship Between Obesity, SIBO, and Metabolism
Research has shown that individuals with obesity are more likely to experience changes in gut microbiota composition. These changes can affect how calories are absorbed, how inflammation is regulated, and how metabolic hormones function.
A study published in Digestive Diseases and Sciences found that SIBO was significantly more prevalent in individuals with obesity compared to non-obese individuals. Other research has linked gut dysbiosis with insulin resistance and altered energy extraction from food.
This is important because many patients begin GLP-1 therapy with pre-existing digestive and metabolic challenges that may not be obvious at first.
Increased energy extraction from food
Certain gut bacteria are more efficient at extracting calories from food. Methane-producing organisms, in particular, have been associated with slower intestinal transit and increased energy absorption. Research published in the American Journal of Gastroenterology has shown a relationship between methane on breath testing and constipation, which can further slow digestion.
Even with reduced food intake, increased calorie extraction can make weight loss more difficult.
Disruption of appetite and metabolic hormones
The gut plays a critical role in hormone regulation, including GLP-1, insulin, ghrelin, and peptide YY. Bacterial overgrowth can disrupt these signaling pathways, making the body less responsive to appetite cues and metabolic regulation.
Chronic low-grade inflammation
SIBO can contribute to inflammation within the intestinal lining. Chronic inflammation has been linked to insulin resistance and impaired fat metabolism, both of which can interfere with weight loss progress.
Nutrient malabsorption
Clinical guidance from gastroenterology organizations notes that SIBO may be associated with nutrient deficiencies, including vitamin B12 and iron. When nutrient absorption is impaired, energy levels, thyroid function, and metabolic efficiency may suffer.
Many GLP-1 patients experience temporary digestive symptoms when starting treatment or adjusting doses. Because bloating and constipation are expected side effects for some individuals, persistent symptoms may be dismissed or normalized.
However, when digestive discomfort continues for weeks or months, or when it coincides with a prolonged weight loss plateau, further evaluation may be appropriate. Gastroenterology guidelines emphasize that persistent symptoms warrant investigation rather than assumption.
Breath testing is a widely used, noninvasive method for evaluating bacterial fermentation patterns in the gut. The American College of Gastroenterology recognizes hydrogen and methane breath testing as a diagnostic tool when SIBO is suspected.
The test measures gas production after ingestion of a specific substrate. Elevated hydrogen or methane levels can help identify bacterial overgrowth and provide insight into gut motility patterns.
Interested in testing for SIBO?
Our office offers convenient at-home SIBO breath testing. We can ship the test directly to you for use in the comfort of your home.
In-home testing is available for $225.
Call (602) 441-3305 to learn more and see if testing is right for you.
Treatment for SIBO is individualized and should be guided by a healthcare provider. Clinical guidelines describe antibiotics as a primary treatment option in many cases, often combined with dietary strategies and motility support.
Management may include:
Many patients can continue GLP-1 therapy while addressing gut health, depending on symptom severity and clinical findings.
You may benefit from speaking with a healthcare provider if you experience:
Addressing gut health does not mean GLP-1 therapy has failed. It often means additional support is needed.
Weight loss is influenced by more than appetite alone. Digestion, hormone signaling, inflammation, and nutrient absorption all play a role in how the body responds to treatment.
By evaluating gut health alongside metabolic care, patients may uncover treatable barriers that allow weight loss strategies to work more effectively and comfortably.
Can SIBO cause weight loss plateaus while on GLP-1 medications?
Yes. SIBO can interfere with digestion, nutrient absorption, and hormone signaling. These factors can contribute to bloating, constipation, and metabolic inefficiency, which may make weight loss slower or stall despite consistent GLP-1 use.
Is bloating normal on GLP-1 medications?
Some bloating can occur, especially during the early stages of treatment or when doses are increased. However, persistent or worsening bloating that does not improve over time may indicate an underlying digestive issue such as slowed gut motility or bacterial overgrowth.
Do GLP-1 medications slow digestion?
Yes. GLP-1 medications are designed to slow gastric emptying and digestion. This helps increase feelings of fullness and regulate blood sugar. In some individuals, slower digestion may also contribute to constipation or digestive discomfort.
What is the connection between gut motility and SIBO?
Healthy gut motility helps move bacteria through the digestive tract. When motility slows, bacteria can remain in the small intestine longer than intended, increasing the risk of bacterial overgrowth. Slower motility is a known factor in SIBO development.
How is SIBO diagnosed?
SIBO is commonly evaluated using a breath test that measures hydrogen and methane gases after consuming a test solution. This noninvasive test helps identify bacterial fermentation patterns that may indicate overgrowth.
Can SIBO be treated while continuing GLP-1 therapy?
In many cases, yes. Treatment plans are individualized, but addressing gut health does not always require stopping GLP-1 medication. A healthcare provider can determine the safest and most effective approach based on symptoms and test results.
Does constipation affect weight loss results?
Constipation can increase bloating, discomfort, and day-to-day scale fluctuations. It can also slow digestive transit further, which may affect how the body processes nutrients and responds to weight loss efforts.
When should I talk to a provider about digestive symptoms?
You should consider speaking with a healthcare provider if you experience ongoing bloating, constipation, abdominal discomfort, fatigue, or a prolonged weight loss plateau that does not improve with time or standard adjustments.
Can gut health affect metabolism?
Yes. Gut health plays an important role in hormone regulation, inflammation, nutrient absorption, and energy balance. Digestive imbalances can influence how the body responds to weight loss treatments.
Are digestive symptoms a sign that GLP-1 medications are not working?
Not necessarily. Digestive symptoms often reflect how the body is adapting. Persistent symptoms may signal that additional evaluation or support is needed rather than a failure of the medication itself.
If you are experiencing persistent bloating, constipation, or stalled weight loss while on GLP-1 therapy, testing for SIBO may provide helpful insight.
Our team offers in-home SIBO breath testing for $225, with tests shipped directly to you.
This content is for educational purposes only and is not intended to diagnose or treat any condition. Individual results may vary. Always consult with a qualified healthcare provider regarding symptoms, medications, or treatment options.
By: The Hidden Epidemic of Sexual Health and What We Can Do
By: Health and wellness technology has exploded in recent years. From smartwatches
How to Stay Motivated with Slow Weight Loss By: You’re doing everything
M, Tues, Thurs, F: 9axm-4:30pm
Sat: 8am-1:30pm
Wed, Sun: Closed